Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PRO- ACTIVE

Financiado

Cerrado

Physical Activity as a Crucial Patient Reported Outcome in COPD

Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have less hospital admissions and better survival. Validated physicalactivity monitors have beco... ver más

31/05/2016

CHIESI

16M€

Presupuesto del proyecto: 16M€

Líder del proyecto

CHIESI FARMACEUTICI SPA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 15 Participantes

Financiación concedida El organismo FP6 notifico la concesión del proyecto el día 2016-05-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

15 Participantes

CHIESI

Lider

CREAL

N.D. | Participante

Fundació Institut Hospital d...

N.D. | Participante

ALMIRALL

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PRO- ACTIVE Physical Activity as a Crucial Patient Reported Outcome in C... 16M€ Cerrado

DPI2015-68820-R BIOMARCADORES FISIOLOGICOS MULTIMODALES PARA LA MONITORIZACI... 235K€ Cerrado

CHRONIOUS An Open Ubiquitous and Adaptive Chronic Disease Management... 10M€ Cerrado

PID2021-126810OB-I00 INTELIGENCIA ARTIFICIAL, SENSORES INTELIGENTES Y NUEVOS PRED... 87K€ Cerrado

STOP-COPD PulseHaler A Novel Treatment Device for COPD. 3M€ Cerrado

EUIN2013-50870 MEDICINA PREDICTIVA PARA LA GESTION INTEGRAL DE CONDICIONES... 15K€ Cerrado

Duración del proyecto: 80 meses Fecha Inicio: 2009-09-01
Fecha Fin: 2016-05-31

Líder del proyecto

CHIESI FARMACEUTICI SPA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 16M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD.More physically active patients have less hospital admissions and better survival. Validated physicalactivity monitors have become available in recent years, and together with patient report of symptomsand distress of physical (in)activity, this may form a potent new Patient Reported Outcome (PRO) in COPD.In response to the IMI-call this consortium will develop and validate two PRO’s. In phase 1, items forthe PRO will be generated based on input from an updated literature survey, expert opinion and patients. One PRO investigates PA on a daily basis, using a user friendly interface. This allows investigating the impact of exacerbations and the dynamics of improvement after initiating treatment. A second PRO is used during clinical trial visits. A unique feature of the PRO’s is that they will include unobtrusive physical activity monitoring. Validity, reproducibility, responsiveness and minimallyclinically meaningful difference of the PRO’s will be investigated. The new PRO’s will be put in thecontext of other, more conventional outcomes. using path-analysis and structural equational modeling.Development will be in compliance to the guidelines of the FDA and in collaboration with EMEA.Iii phase 2 the PRO’s will be used in 3 large multi-center clinical trials. These trials will contribute tothe validity and health economic value of the PRO’s. They tackle contemporary questions in COPDcare, including pharmacotherapy, PA counseling and pulmonary rehabilitation.The consortium is well equipped to develop PRO’s. It includes academic centers with a solid reputationin COPD research, centers with expertise in epidemiology, experts in conducting systematic reviews,PRO-methodology and statistics. Patient associations are in the core of the consortium. A SME willdevelop patient material in various languages.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores